Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is XenoPort, Inc. (XNPT) A Good Stock To Buy?

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Carl Icahn and George Soros think. Those hedge fund operators make billions of dollars each year by hiring the best and the brightest to do research on stocks, including small cap stocks that big brokerage houses simply don’t cover. Because of Carl Icahn and other elite funds’ exemplary historical records, we pay attention to their small cap picks. In this article, we use hedge fund filing data to analyze XenoPort, Inc. (NASDAQ:XNPT).

XenoPort, Inc. (NASDAQ:XNPT)’s stock plunged by 43% in the third quarter, prompting some investors to sell. In this way, among the funds we track, the number of XenoPort shareholders went down by two during the third quarter and XNPT was in 14 hedge funds’ portfolios at the end of September. However, the level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Harte-Hanks, Inc. (NYSE:HHS), and Cambium Learning Group, Inc. (NASDAQ:ABCD) to gather more data points.

Follow Xenoport Inc (NASDAQ:XNPT)
Trade (NASDAQ:XNPT) Now!

In the 21st century investor’s toolkit there are dozens of metrics market participants put to use to size up stocks. Two of the most useful metrics are hedge fund and insider trading sentiment. We have shown that, historically, those who follow the best picks of the best money managers can outpace the broader indices by a significant margin (see the details here).

Keeping this in mind, we’re going to view the latest action surrounding XenoPort, Inc. (NASDAQ:XNPT).

How have hedgies been trading XenoPort, Inc. (NASDAQ:XNPT)?

At the Q3’s end, a total of 14 of the hedge funds tracked by Insider Monkey were bullish on this stock, a decline of 13% from the second quarter. Among these funds, Julian Baker and Felix Baker’s Baker Bros. Advisors has the largest position in XenoPort, Inc. (NASDAQ:XNPT), worth close to $22.6 million, amounting to 0.2% of its total 13F portfolio. Sitting at the No. 2 spot is OrbiMed Advisors, led by Samuel Isaly, holding a $20 million position; 0.2% of its 13F portfolio is allocated to the stock. The remaining members of the smart money that are bullish include James E. Flynn’s Deerfield Management, Steven Boyd’s Armistice Capital, and Ken Griffin’s Citadel Investment Group.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.